Cargando…

Uptake and tolerability of repeated mucosal specimen collection in two Phase 1 AIDS preventive vaccine trials in Kenya

Detalles Bibliográficos
Autores principales:	Mutua, G, Omosa-Manyonyi, G, Park, H, Bergin, P, Laufer, D, Amornkul, PN, Lehrman, J, Fast, P, Gilmour, J, Anzala, O, Farah, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441524/ http://dx.doi.org/10.1186/1742-4690-9-S2-P122

Ejemplares similares

Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2014)

Reasons for Ineligibility in Phase 1 and 2A HIV Vaccine Clinical Trials at Kenya Aids Vaccine Initiative (KAVI), Kenya
por: Omosa-Manyonyi, Gloria S., et al.
Publicado: (2011)

Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2020)

Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults—Experience from Kenya
por: Nyasani, Delvin Kwamboka, et al.
Publicado: (2018)

Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya
por: Podolak, Irene, et al.
Publicado: (2017)

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus–Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens
por: Nyombayire, Julien, et al.
Publicado: (2017)

Assessment of hepatitis B vaccination status and hepatitis B surface antibody titres among health care workers in selected public health hospitals in Kenya
por: Mwangi, Irene Ann, et al.
Publicado: (2023)

Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials
por: Langat, Robert K., et al.
Publicado: (2021)

Factors associated with repeat induced abortion in Kenya
por: Maina, Beatrice W., et al.
Publicado: (2015)

Cultured enzyme-linked immunospot assay (ELISPOT) enhances detection of low HIV-specific immune responses in exposed seronegative individuals in Kenya
por: Muturi, Margaret, et al.
Publicado: (2006)

Evaluation and optimization of the syndromic management of female genital tract infections in Nairobi, Kenya
por: Omosa-Manyonyi, Gloria S., et al.
Publicado: (2023)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
por: Nyaoke, Borna A., et al.
Publicado: (2017)

Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya
por: Chanzu, Nadia Musimbi, et al.
Publicado: (2015)

Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya
por: Wahome, Elizabeth, et al.
Publicado: (2016)

CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
por: Karita, Etienne, et al.
Publicado: (2009)

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
por: Jaoko, Walter, et al.
Publicado: (2010)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
por: Mpendo, Juliet, et al.
Publicado: (2015)

Acceptance of Treatment of Sexually Transmitted Infections for Stable Sexual Partners by Female Sex Workers in Kampala, Uganda
por: Mayanja, Yunia, et al.
Publicado: (2016)

P06-08. Building an African HIV preventive trial network
por: Price, MA, et al.
Publicado: (2009)

Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda
por: Mayanja, Yunia, et al.
Publicado: (2023)

Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial
por: Mpendo, Juliet, et al.
Publicado: (2020)

Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya
por: Mutua, Gaudensia, et al.
Publicado: (2019)

Improving family planning services delivery and uptake: experiences from the “Reversing the Stall in Fertility Decline in Western Kenya Project”
por: Amo-Adjei, Joshua, et al.
Publicado: (2017)

A Qualitative Study on Gendered Barriers to Livestock Vaccine Uptake in Kenya and Uganda and Their Implications on Rift Valley Fever Control
por: Mutua, Edna, et al.
Publicado: (2019)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa
por: Amornkul, Pauli N., et al.
Publicado: (2013)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults
por: Omosa-Manyonyi, Gloria, et al.
Publicado: (2015)

Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission
por: Kamali, Anatoli, et al.
Publicado: (2015)

Antimicrobial Resistance Profiles of Bacteria Isolated from the Nasal Cavity of Camels in Samburu, Nakuru, and Isiolo Counties of Kenya
por: Mutua, J. M., et al.
Publicado: (2017)

Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya
por: Mugo, Peter Mwangi, et al.
Publicado: (2014)

Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya
por: Mutisya, Elizabeth Mueni, et al.
Publicado: (2022)

Developing standards of care for HIV prevention research in developing countries – a case study of ten research centers in Eastern and Southern Africa
por: Ngongo, BP, et al.
Publicado: (2012)

Epidemiological and clinical characteristics of patients hospitalised with COVID-19 in Kenya: a multicentre cohort study
por: Ombajo, Loice Achieng, et al.
Publicado: (2022)

Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya
por: Maina, Anne Njeri, et al.
Publicado: (2016)

Possibilities of establishing a smallholder pig identification and traceability system in Kenya
por: Mutua, Florence, et al.
Publicado: (2019)

Investigating the Influence of Land Use and Alcohol Outlet Density on Crime in Juja Sub-County, Kenya
por: Mburu, Eileen, et al.
Publicado: (2023)

Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care
por: Agutu, Clara A., et al.
Publicado: (2019)

Volunteer public leaders’ values-driven leadership: the case of village elders in Kenya
por: Mutua, Jacqueline Nthoki, et al.
Publicado: (2021)

Host genetics and viral load in primary HIV-1 infection: clear evidence for gene by sex interactions
por: Li, Xuelin, et al.
Publicado: (2014)

Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials
por: Mbogua, J, et al.
Publicado: (2012)

Urinary interleukins (IL)-6 and IL-10 in schoolchildren from an area with low prevalence of Schistosoma haematobium infections in coastal Kenya
por: Njaanake, Kariuki H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5ghreupbrcuvkef211bb1d2o8r